Showing results (2221-2230 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|August 14, 2020
Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapySumi Yun, Jiwon Koh, Soo Kyung Nam, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2015
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphomaTakumi Kumai, Toshihiro Nagato, Hiroya Kobayashi, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classesC Fuchs, F Krapf, P Kern, et al.
Cancer Immunology, Immunotherapy : CII|March 26, 2021
Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancerWon Ik Seo, Chan Ho Lee, Soo Jin Jung, et al.
Cancer Immunology, Immunotherapy : CII|April 11, 2023
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemiaChristian Sordo-Bahamonde, Seila Lorenzo-Herrero, Alejandra Martínez-Pérez, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2023
Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expressionTatsuo Furuya, Shunta Ishihara, Hiroshi Ogi, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2023
Engineered murine IL-21-secreting leukemia cells induce granzyme B+ T cells and CD4+CD44+CD62L- effector memory cells while suppressing regulatory T cells, leading to long-term survivalAlexandra Berger, Sarah J Colpitts, Morgan Zych, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2020
Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicityYan Wang, Haiqing Ni, Shuaixiang Zhou, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2020
Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumorsJenny Ling-Yu Chen, Chun-Kai Pan, Yu-Sen Huang, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2020
Increased Th17 activation and gut microbiota diversity are associated with pembrolizumab-triggered tuberculosisYun-Bin Zhang, Shi-Jia Liu, Zhi-Dong Hu, et al.
Pageof 652